Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs RIO✓SelectedUSD · RIOGSK vs RIO performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs RIO

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+41.1%
RIO return
+68.3%
Excess return
-27.1%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioRIOExcessAlpha
1D-0.1%-2.6%+2.5%+0.4%
7D-5.3%-12.3%+7.0%-3.0%
30D-3.7%-16.3%+12.7%-0.5%
3M-7.3%-28.8%+21.6%-1.5%
6M-4.2%-28.1%+23.8%+1.2%
YTD+0.9%-4.5%+5.4%+0.4%
1Y+7.3%+11.1%-3.8%+3.5%
3Y+52.7%+25.6%+27.2%+42.5%
All+41.1%+68.3%-27.1%+21.6%

Cumulative growth

Daily Returns

Daily percentage return beside RIO.

Daily Out/Under-Performance

Portfolio return minus RIO return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × RIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded RIO wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling